UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046274
Receipt number R000052785
Scientific Title Usefulness of 22G needle in endoscopic ultrasound-guided biliary drainage (EUS-BD).
Date of disclosure of the study information 2021/12/06
Last modified on 2021/12/03 20:47:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of 22G needle in endoscopic ultrasound-guided biliary drainage (EUS-BD).

Acronym

Usefulness of 22G needle in endoscopic ultrasound-guided biliary drainage (EUS-BD).

Scientific Title

Usefulness of 22G needle in endoscopic ultrasound-guided biliary drainage (EUS-BD).

Scientific Title:Acronym

Usefulness of 22G needle in endoscopic ultrasound-guided biliary drainage (EUS-BD).

Region

Japan


Condition

Condition

Malignant biliary obstruction

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will demonstrate the safety and efficacy of EUS-BD using a 22G puncture needle and 0.018inch guidewire compared to EUS-BD using a conventional 19G puncture needle.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Accuracy between the target angle and the actual puncture angle during the initial bile duct puncture

Key secondary outcomes

technical sucsess, stenting success on first puncture, first puncture success within tolerance (2 degrees), number of punctures required, procedure time, clinical response rate, duration of stent function maintenance, incidents, overall survival (up to 1 year)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Adopt 22G as the puncture needle for EUS-BD

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

atients who can be diagnosed as malignant biliary obstruction by imaging and pathology, and who are expected to have difficulty in trans-papillary drainage by ERCP for any of the following reasons, and who are eligible for EUS-BD and have obtained written consent
1) Gastrointestinal invasion is suspected on imaging, and it is difficult or expected to be difficult to reach the main papilla endoscopically.
2) Patients with postoperative reconstructed intestine, and difficulty in reaching the main papilla by lateral viewing duodenoscope is expected.
3) Unsuccessful drainage by ERCP

Key exclusion criteria

Less than 20 years old
Intrahepatic bile duct diameter less than 3 mm
EUS-BD puncture line cannot avoid metastatic liver tumor
Large amount of ascites
Poorly controlled infections
Severe drug allergy.
Pregnant or potentially pregnant and lactating women
Severe mental disorder
Patients who are judged by the principal investigator or sub-investigator to be unsuitable for the safe conduct of this study.

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Takuya
Middle name
Last name Ishikawa

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

466-8550

Address

65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.

TEL

052-744-2602

Email

ishitaku@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Kota
Middle name
Last name Uetsuki

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

466-8550

Address

65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.

TEL

052-744-2602

Homepage URL


Email

uetsukik@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Nagoya University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

Address

65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.

Tel

052-744-2602

Email

uetsukik@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 12 Month 03 Day

Date of IRB


Anticipated trial start date

2022 Year 01 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 03 Day

Last modified on

2021 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052785


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name